Clinical and Experimental Obstetrics & Gynecology,
Год журнала:
2024,
Номер
51(9)
Опубликована: Сен. 14, 2024
Objective:
This
review
summarizes
the
molecular
properties,
anticancer
effects,
and
bioavailability
of
quercetin
(Que).
We
discussed
its
role
in
preventing
treating
gynecologic
cancers,
assisting
treatment
drug-resistant
cases,
synergizing
with
other
treatments.
includes
an
analysis
Que’s
impact
on
breast,
ovarian,
cervical
cancer.
Mechanism:
Gynecologic
cancers
are
a
significant
cause
cancer-related
deaths,
leading
to
low
survival
rates
high
burden
patients
healthcare
systems.
They
regarded
as
major
health
problem
women.
The
use
complementary
therapies,
such
Que,
can
contribute
improving
patient
outcomes
quality
life.
utilization
medicinal
plants
alternative
medicine
(CAM)
is
rise
worldwide,
offering
new
approaches
cancer
treatment.
approach
may
provide
potential
treatments
for
various
including
female
cancer,
either
alone
or
combination
medications.
Findings
Brief:
Among
natural
compounds,
Que
commonly
used
anti-cancer
supplement
due
antioxidant
anti-inflammatory
properties.
effective
dose-
time-dependent
manner,
demonstrated
by
numerous
vitro
vivo
studies
experiments.
However,
more
clinical
required
establish
this
flavonoid
therapeutic
agent
part
drug
humans.
Conclusions:
helps
prevent
treat
gynecological
reduce
resistance,
increase
effectiveness
chemical
drugs
radiotherapy.
It
achieves
through
anti-inflammatory,
pro-oxidative,
anti-proliferative,
induction
apoptosis,
cell
cycle
arrest
mechanisms.
human
needed
accurately
determine
mechanisms
action
extent
effectiveness.
Cancer Cell International,
Год журнала:
2025,
Номер
25(1)
Опубликована: Янв. 27, 2025
Theranostics
is
a
way
of
treating
illness
that
blends
medicine
with
testing.
Specific
characteristics
should
be
present
in
the
best
theranostic
agents
for
cancer:
(1)
drugs
safe
and
non-toxic;
(2)
they
able
to
treat
cancer
selectively;
(3)
build
up
only
cancerous
tissue.
Liposomes
(LPs)
are
one
most
efficient
drug
delivery
methods
based
on
nanotechnology.
Stealth
LPs
commercial
have
recently
had
an
impact
treatment.
Using
valuable
information
from
each
imaging
technique,
along
multimodality
functionality
liposomal
therapeutic
agents,
makes
them
very
appealing
personalized
monitoring
how
well
working
against
vivo
predicting
therapies
will
work.
On
other
hand,
their
use
as
nanoparticle
systems
currently
research
development
phase.
Nanoscale
system
innovation
has
made
LP-nanoparticle
hybrid
structures
useful
combining
methods.
LP-hybrid
nanoparticles
better
at
killing
cells
than
LP
counterparts,
making
excellent
options
vitro
applications.
Hybrid
liposomes
(HLs)
could
used
future
carriers
find
targets.
This
would
combine
features
synthetic
biological
systems.
Overarchingly,
this
article
provided
comprehensive
overview
many
types
detection,
therapy,
analysis.
An
evaluation
pros
cons
HLs
detection
treatment
also
been
conducted.
The
study
included
recent
significant
We
conclude
by
outlining
potential
benefits
drawbacks
approach
concurrent
different
malignancies,
its
prospects.
Drug Development and Industrial Pharmacy,
Год журнала:
2024,
Номер
unknown, С. 1 - 14
Опубликована: Авг. 5, 2024
Cancers
are
regarded
as
hazardous
due
to
their
high
worldwide
death
rate,
with
breast
cancer
(BC),
which
affects
practically
all
patients
globally,
playing
a
significant
role
in
this
statistic.
The
therapeutic
approach
for
BC
has
not
advanced
using
standard
techniques,
such
specialized
naringin
(NG)
chemotherapy.
Instead,
novel
strategy
been
utilized
enhance
smart
drug
delivery
(SDD)
tumors.
Drug Development and Industrial Pharmacy,
Год журнала:
2024,
Номер
50(6), С. 561 - 575
Опубликована: Июнь 2, 2024
Breast
cancer
(BC)
is
the
most
common
malignancy
in
women
globally.
Significant
progress
has
been
made
developing
structural
nanoparticles
(NPs)
and
formulations
for
targeted
smart
drug
delivery
(SDD)
of
pharmaceuticals,
improving
precision
tumor
cell
targeting
therapy.
